The Comparative Release of FGF1 by Hypoxia and Temperature Stress

References

• Ananyeva N. M, Tijurmin A. V, Berliner J A., Chisolm G. M, Liau G., Winkles J. A, Haudenschild C. C. Oxidized LDL mediates the release of fibroblast growth factor-1. Arterioscler. Thromb. Vase. Biol. 1997; 17: 445–453
   PubMed Web of Science ®Google Scholar
• Burgess W. H, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 1989; 58: 575–606
   PubMed Web of Science ®Google Scholar
• Carreira C, La Vallee T., Tarantini F., Jackson A., Lathrop J., Hampton B., Burgess W., Maciag T. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J. Biol. Chem. 1998; 273: 22224–22231
   PubMedGoogle Scholar
• Dirks W., MacLeod R., Drexler H. ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev. Biol. 1999; 35: 558–559
   Web of Science ®Google Scholar
• Donato R. S-100 proteins: relationships with membranes and the cytoskeleton. Adv. Exp. Med. Biol. 1990; 269: 103–106
   PubMedGoogle Scholar
• Forough R., Zhan X., MacPhee M., Friedman S., Engleka K. A, Sayers T., Wiltrout R. H, Maciag T. Differential transforming abilities of non-secreted forms of human fibroblast growth factor-1. J. Biol. Chem. 1993; 268: 2960–2968
   PubMed Web of Science ®Google Scholar
• Forsythe J., Jiang B., Iyer N., Agani F., Leung S., Koos R., Semenza G. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mot. Cell. Biol. 1996; 16: 4604–4613
   Web of Science ®Google Scholar
• Friesel R., Maciag T. Fibroblast growth factor prototype release and fibroblast growth factor receptor signaling. Thromb. Haemost. 1999; 82: 748–754
   PubMed Web of Science ®Google Scholar
• Fukumura D., Xavier R., Sugiura T., Chen Y., Park E., Lu N., Selig M., Nielsen G., Taksir T., Jain R., Seed B. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998; 94: 715–725
   PubMed Web of Science ®Google Scholar
• Jackson A., Friedman S., Zhan X., Engleka K. A, Forough R., Maciag T. Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 1992; 89: 10691–10695
   PubMed Web of Science ®Google Scholar
• Jackson A., Tarantini F., Gamble S., Friedman S., Maciag T. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem. 1995; 270: 33–36
   PubMed Web of Science ®Google Scholar
• Jouanneau J., Moens G., Montesano R., Thiery J. FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation. Growth Factors 1995; 12: 37–47
   PubMed Web of Science ®Google Scholar
• Kato S., Sekine K. FGF-FGFR signaling in vertebrate organogenesis. Cell Mol. Biol. 1999; 45: 631–638
   PubMed Web of Science ®Google Scholar
• Klint P., Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Fron. in Biosci. 1999; 4: 165–177
   PubMedGoogle Scholar
• Landriscina M., Prudovsky I., Mouta C. Carreira, Soldi R., Tarantini F., Maciag T. Amlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fibers in vitro. J. Biol. Chem. 2000; 275: 32753–32762
   PubMed Web of Science ®Google Scholar
• La Vallee T., Tarantini F., Gamble S., Mouta Carreira C., Jackson A., Maciag T. Synaptotagmin-1 is required for fibroblast growth factor-1 release. J. Biol. Chem. 1998; 273: 22217–22223
   PubMedGoogle Scholar
• Miller B., Baier L., Morrison. Overexpression of protein kinase C-zeta isoform increases cyclooxygenase-2 and inducible nitric oxide synthase. Am. J. Physiol. 1997; 273: C130–C136
   PubMedGoogle Scholar
• Nabel E. G, Yang Z.-Y., Plautz G., Forough R., Zhan X., Haudenschild C. C, Maciag T., Nabel G. J. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 1993; 362: 844–846
   PubMed Web of Science ®Google Scholar
• Pelham H. Multiple targets for brefeldin A. Cell 1991; 67: 449–451
   PubMed Web of Science ®Google Scholar
• Plouet J., Mascarelli F., Loret M. D, Faure J. P, Courtois Y. Regulation of eye derived growth factor binding to membranes by light, ATP or GTP in photo-receptor outer segments. EMBO J. 1988; 7: 373–376
   PubMed Web of Science ®Google Scholar
• Robinson M., Overbeek P., Verran D., Grizzle W., Stockard C., Friesel R., Maciag T., Thompson J. Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice. Development, 121: 505–514
   PubMedGoogle Scholar
• Saijo T., Makino H., Tamura S., Kuriki H., Ashida Y., Terao S., Maki Y. The antiallergic agent amoxanox suppresses SRS-A generation by inhibiting lipoxygenase. Int. Arch. Allergy. Appl, Immunol. 1986; 79: 231–237
   PubMedGoogle Scholar
• Schiavo G., Osborne S. L, Sgouros J. G. Synaptotagmins: more isoforms than functions?. Biochem. Biophys. Res. Commun. 1998; 248: 1–8
   PubMedGoogle Scholar
• Shi J., Friedman S., Maciag T. A carboxyl-terminal domain in fibroblast growth factor (FGF)-2 inhibits FGF-1 release in response to heat shock in vitro. J. Biol. Chem. 1997; 272: 1142–1147
   PubMedGoogle Scholar
• Shin J. T, Opalenik S. R, Wehby J. N, Mahesh V. K, Jackson A., Tarantini F., Maciag T., Thompson J. A. Serum-starvation induces the extracellular appearance of FGF-1. Biochim. Biophys. Acta. 1996; 1312: 27–38
   PubMed Web of Science ®Google Scholar
• Shishibori T., Oyama Y., Matsushita O., Yamashita K., Furuichi H., Okabe A., Maeta H., Hata Y., Kobayashi R. Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family. Biochem. J. 1999; 338: 583–589
   PubMedGoogle Scholar
• Tarantini F., Gamble S., Jackson A., Maciag T. The cysteine residue responsible for the release of fibroblast growth factor-1 resides in a domain independent of the domain for phosphatidylserine binding. J. Biol. Chem. 1995; 270: 29039–29042
   PubMed Web of Science ®Google Scholar
• Tarantini F., La Vallee T., Jackson A., Gamble S., Mouta Carreira C., Garfinkel S., Burgess W. H, Maciag T. The extra vesicular domain of synaptotagmin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J. Biol. Chem. 1998; 273: 22209–22216
   PubMed Web of Science ®Google Scholar
• Van Wauwe J., Goosens J. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets: comparison with indomethacin and ETYA. Prostaglandins 1983; 26: 725–730
   PubMed Web of Science ®Google Scholar
• Vezza R., Habib A., Li H., Lawson J., FitzGerald G. Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation. J. Bio. Chem., 271: 30028
   PubMedGoogle Scholar
• Watkins M., Haudenschild C., al-Badawi H., Velazquez F., Larson D. Immediate responses of endothelial cells to hypoxia and reoxygenation: an in vitro model of cellular dysfunction. Am. J. Physiol. 1995; 268: 749–758
   Google Scholar
• Wicki R., Schafer B. W, Erne P., Heizmann C. W. Characterization of the human and mouse cDNAs coding for S100A13, a new member of the S100 protein family. Biochem. Biophys. Res. Commun. 1996; 227: 594–599
   PubMedGoogle Scholar
• Yayon A., Klagsbrun M. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc. Natl. Acad. Sci. USA 1990; 87: 5346–5350
   PubMedGoogle Scholar